Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Nuclear Medicine|September 28, 2021
18F-Fluciclovine-Avid Pulmonary HamartomaSacha C Baldeosingh, Steven P Rowe, Stephen C Greco, et al.
Urology|October 7, 2023
Effect of Transperineal Versus Transrectal Prostate Biopsy on the Quality of Hydrogel Spacer Placement in Men Prior to Radiation Therapy for Prostate CancerMichael E Rezaee, Ulysses Gardner, Mark N Alshak, et al.
Medical Oncology (Northwood, London, England)|April 28, 2022
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancerDiane K Reyes, Bruce J Trock, Phuoc T Tran, et al.
Urologic Oncology|March 20, 2018
Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapyLuke C Peng, Amol K Narang, Carol Gergis, et al.
JAMA Oncology|March 28, 2020
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical TrialRyan Phillips, William Yue Shi, Matthew Deek, et al.
BMC Cancer|June 4, 2020
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)Hamza Hasan, Matthew P Deek, Ryan Phillips, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2025
Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized TrialJarey H Wang, Alexander D Sherry, Soha Bazyar, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium StudyKiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
European Urology|April 18, 2019
Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective AnalysisKiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
Pageof 1